Literature DB >> 8719037

Neurotensin receptors: binding properties, transduction pathways, and structure.

J P Vincent1.   

Abstract

Neurotensin is a 13-amino acid peptide (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) originally isolated from hypothalami (Carraway and Leeman, 1973) and later from intestines (Kitabgi et al., 1976) of bovine. The peptide is present throughout the animal kingdom, suggesting its participation to important processes basic to animal life (Carraway et al., 1982). Neurotensin and its analogue neuromedin-N (Lys-Ile-Pro-Tyr-Ile-Leu) (Minamino et al., 1984) are synthesized by a common precursor in mammalian brain (Kislauskis et al., 1988) and intestine (Dobner et al., 1987). The central and peripheral distribution and effects of neurotensin have been extensively studied. In the brain, neurotensin is exclusively found in nerve cells, fibers, and terminals (Uhl et al., 1979), whereas the majority of peripheral neurotensin is found in the endocrine N-cells located in the intestinal mucosa (Orci et al., 1976; Helmstaedter et al., 1977). Central or peripheral injections of neurotensin produce completely different pharmacological effects (Table I) indicating that the peptide does not cross the blood-brain barrier. Many of the effects of centrally administered neurotensin are similar to those of neuroleptics or can be antagonized by simultaneous administration of TRH (Table I). The recently discovered nonpeptide antagonist SR 48692 (Gully et al., 1993) can inhibit several of the central and peripheral effects of neurotensin (Table I). Like many other neuropeptides, neurotensin is a messenger of intracellular communication working as a neurotransmitter or neuromodulator in the brain (Nemeroff et al., 1982) and as a local hormone in the periphery (Hirsch Fernstrom et al., 1980). Thus, several pharmacological, morphological, and neurochemical data suggest that one of the functions of neurotensin in the brain is to regulate dopamine neurotransmission along the nigrostriatal and mesolimbic pathways (Quirion, 1983; Kitabgi, 1989). On the other hand, the likely role of neurotensin as a parahormone in the gastrointestinal tract has been well documented (Rosell and Rökaeus, 1981; Kitabgi, 1982). Both central and peripheral modes of action of neurotensin imply as a first step the recognition of the peptide by a specific receptor located on the plasma membrane of the target cell. Formation of the neurotensin-receptor complex is then translated inside the cell by a change in the activity of an intracellular enzyme. This paper describes the binding and structural properties of neurotensin receptors as well as the signal transduction pathways that are activated by the peptide in various target tissues and cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719037     DOI: 10.1007/BF02071313

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  65 in total

1.  Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways.

Authors:  P Kitabgi
Journal:  Neurochem Int       Date:  1989       Impact factor: 3.921

2.  Stable expression of the cloned rat brain neurotensin receptor into fibroblasts: binding properties, photoaffinity labeling, transduction mechanisms, and internalization.

Authors:  J Chabry; C Labbé-Jullié; D Gully; P Kitabgi; J P Vincent; J Mazella
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

3.  The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.

Authors:  I Dubuc; J Costentin; J P Terranova; M C Barnouin; P Soubrié; G Le Fur; W Rostène; P Kitabgi
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

4.  Evidence for immunoreactive neurotensin in dog intestinal mucosa.

Authors:  L Orci; O Baetens; C Rufener; M Brown; W Vale; R Guillemin
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

5.  High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.

Authors:  F Checler; J Mazella; P Kitabgi; J P Vincent
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

6.  Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29.

Authors:  S Amar; P Kitabgi; J P Vincent
Journal:  FEBS Lett       Date:  1986-05-26       Impact factor: 4.124

7.  Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: immunohistochemical mapping.

Authors:  G R Uhl; R R Goodman; S H Snyder
Journal:  Brain Res       Date:  1979-05-05       Impact factor: 3.252

8.  Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: apparent conservation of the COOH-terminal region during evolution.

Authors:  R Carraway; S E Ruane; H R Kim
Journal:  Peptides       Date:  1982 Mar-Apr       Impact factor: 3.750

9.  Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution.

Authors:  P Kitabgi; W Rostène; M Dussaillant; A Schotte; P M Laduron; J P Vincent
Journal:  Eur J Pharmacol       Date:  1987-08-21       Impact factor: 4.432

10.  Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.

Authors:  N Vita; P Laurent; S Lefort; P Chalon; X Dumont; M Kaghad; D Gully; G Le Fur; P Ferrara; D Caput
Journal:  FEBS Lett       Date:  1993-02-08       Impact factor: 4.124

View more
  20 in total

1.  Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Authors:  I Dubuc; P Sarret; C Labbé-Jullié; J M Botto; E Honoré; E Bourdel; J Martinez; J Costentin; J P Vincent; P Kitabgi; J Mazella
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

Review 2.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Neurotensin induces hypothermia by activating both neuronal neurotensin receptor 1 and astrocytic neurotensin receptor 2 in the median preoptic nucleus.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2020-04-08       Impact factor: 5.250

4.  Intrathecal neurotensin is hypotensive, sympathoinhibitory and enhances the baroreflex in anaesthetized rat.

Authors:  B Zogovic; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  Postnatal nitric oxide inhibition modifies neurotensin effect on ATPase activity.

Authors:  María Graciela López Ordieres; Anabel Álvarez-Juliá; Alma Kemmling; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2011-07-29       Impact factor: 3.996

6.  Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation.

Authors:  S Y Choi; H D Chae; T J Park; H Ha; K T Kim
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 7.  Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.

Authors:  T Antonelli; M C Tomasini; K Fuxe; L F Agnati; S Tanganelli; L Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2006-09-19       Impact factor: 3.575

8.  Effects of the Hybridization of Opioid and Neurotensin Pharmacophores on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Patrycja Kleczkowska; Maria Kawalec; Magdalena Bujalska-Zadrozny; Małgorzata Filip; Barbara Zablocka; Andrzej W Lipkowski
Journal:  Neurotox Res       Date:  2015-08-19       Impact factor: 3.911

9.  Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.

Authors:  Yinnong Jia; Wen Shi; Zhengyuan Zhou; Nilesh K Wagh; Wei Fan; Susan K Brusnahan; Jered C Garrison
Journal:  Nucl Med Biol       Date:  2015-07-29       Impact factor: 2.408

10.  The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog.

Authors:  D Feifel; S Mexal; Gilia Melendez; Philip Y T Liu; Joseph R Goldenberg; Paul D Shilling
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.